Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 28, 2006

View Archived Issues

MK-0518 combination therapy yields HIV RNA reduction at 24 weeks

Novel antiarthritic compounds described in recent patents

Trimeris and Roche report on new potent fusion inhibitors with potential for once-weekly dosing

Insulin-stimulating properties of Hon-Chi reported

Targeting the pronociceptive action of CCK-8 for diabetes-induced peripheral sensitization

Novel treatment strategies for respiratory disorders claimed in recent patents

Ono patent discloses new compounds for treating HIV infection

ADA and EASD issue consensus statement on metformin treatment

Preliminary analysis from MEDAL program for Arcoxia

NeuroSearch to acquire Carlsson Research

CK-1827452 studied for oral administration

VivaGel studied for safety in men

Zileuton i.v. improves FEV1 in asthma patients

TPM-02/Insulin successfully delivers insulin across skin

Epigenetic targeting in psychopharmacology - a new avenue of research

KC-706 set to advance into phase II for inflammatory conditions

MGCD-0103 studied in phase II trial for relapsed or refractory Hodgkin's disease

NuPathe licenses LAD long acting delivery technology from U. of Pennsylvania

Dendreon submits sections of rolling BLA for Provenge

BrainStorm Cell Therapeutics to target stroke with adult stem cell technology

PXD-101 studied in aggressive B-cell lymphoma

GSK and ChemoCentryx establish strategic alliance in inflammatory disorders

Guanfacine extended release NDA filed for ADHD

ImmunoVaccine Technologies to use PADRE for vaccines

GlaxoSmithKline's Relenza approved in 15 E.U. countries

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...